These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 4361978)

  • 1. Immunity to murine sarcoma virus-inducted tumors. II. Suppression of T cell-mediated immunity by cells from progressor animals.
    Gorczynski RM
    J Immunol; 1974 May; 112(5):1826-38. PubMed ID: 4361978
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunity to murine sarcoma virus-inducted tumors. I. Specific T lymphocytes active in macrophage migration inhibition and lymphocyte transformation.
    Gorczynski RM
    J Immunol; 1974 May; 112(5):1815-25. PubMed ID: 4361977
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence for in vivo protection against murine-sarcoma virus-induced tumors by T lymphocytes from immune animals.
    Gorczynski RM
    J Immunol; 1974 Feb; 112(2):533-9. PubMed ID: 4360545
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative in vitro studies on effector cell diversity in the cellular immune response to murine sarcoma virus (MSV)-induced tumors in mice.
    Plata F; Gomard E; Leclerc JC; Levy JP
    J Immunol; 1974 Apr; 112(4):1477-87. PubMed ID: 4360862
    [No Abstract]   [Full Text] [Related]  

  • 5. The participation of thymus-derived and of bone marrow-derived lymphocytes of sensitized mice, in the proliferative response to specific antigen, in vitro.
    Mugraby L; Gery I; Sulitzeanu D
    Eur J Immunol; 1974 Jun; 4(6):402-5. PubMed ID: 4607213
    [No Abstract]   [Full Text] [Related]  

  • 6. Host responses to infectious bovine rhinotracheitis virus. III. Isolation and immunologic activities of bovine T lymphocytes.
    Rouse BT; Babiuk LA
    J Immunol; 1974 Nov; 113(5):1391-8. PubMed ID: 4370600
    [No Abstract]   [Full Text] [Related]  

  • 7. Stimulation of early protein synthesis as an assay of immune reactivity: analysis of the cells responding to mitogens and alloantigens.
    Gorczynski RM; Rittenberg MB
    J Immunol; 1974 Jan; 112(1):47-55. PubMed ID: 4272923
    [No Abstract]   [Full Text] [Related]  

  • 8. [Mitogenic activity of a bacterial phospholipid extract on murine lymphocytes (author's transl)].
    Marchal G; Fauve RM
    Ann Immunol (Paris); 1974; 125(3):507-18. PubMed ID: 4605791
    [No Abstract]   [Full Text] [Related]  

  • 9. In vivo and in vitro responses to tumor-associated antigens: apparent absence of T cell participation.
    Tyan ML
    Eur J Immunol; 1974 Nov; 4(11):727-31. PubMed ID: 4609770
    [No Abstract]   [Full Text] [Related]  

  • 10. Tumor inhibiting capacity of spleen and lymph node cells from mice with murine sarcoma virus (MSV-M)-induced tumors.
    Weiland E; Mussgay M
    Z Immunitatsforsch Exp Klin Immunol; 1975 Nov; 150(5):414-23. PubMed ID: 181922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune response and leukemia virus infection in the mouse.
    Collavo D; Biasi G; Colombatti A; Chieco-Bianchi L
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:296. PubMed ID: 4604562
    [No Abstract]   [Full Text] [Related]  

  • 12. Functional heterogeneity among the T-derived lymphocytes of the mouse. IV. Nature of spontaneously induced suppressor cells.
    Burns FD; Marrack PC; Kappler JW; Janeway CA
    J Immunol; 1975 Apr; 114(4):1345-7. PubMed ID: 123261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The response of rabbit lymphocytes to mitogens and alloantigens: evidence for T cell heterogeneity.
    Ozer H; Waksman BH
    J Immunol; 1974 Dec; 113(6):1780-92. PubMed ID: 4279263
    [No Abstract]   [Full Text] [Related]  

  • 14. Correction of T cell function by thymosin in New Zealand mice.
    Gershwin ME; Ahmed A; Steinberg AD; Thurman GB; Goldstein AL
    J Immunol; 1974 Sep; 113(3):1068-71. PubMed ID: 4606393
    [No Abstract]   [Full Text] [Related]  

  • 15. Two functionally distinct anti-tumor effector cells isolated from primary murine sarcoma virus-induced tumors.
    Holden HT; Haskill JS; Kirchner H; Herberman RB
    J Immunol; 1976 Aug; 117(2):440-6. PubMed ID: 1084897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunity to tumours of the murine leukaemia-sarcoma virus complex.
    Owen JJ; Seeger RC
    Br J Cancer Suppl; 1973 Aug; 1():26-34. PubMed ID: 4374230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of macrophages in the production of lymphokines by T and B lymphocytes.
    Wahl SM; Wilton JM; Rosenstreich DL; Oppenheim JJ
    J Immunol; 1975 Apr; 114(4):1296-301. PubMed ID: 1090672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of bacterial products on lymphocytes and macrophages: their possible role in natural resistance to listeria infetion in mice.
    Petit JC; Unanue ER
    J Immunol; 1974 Sep; 113(3):984-92. PubMed ID: 4213069
    [No Abstract]   [Full Text] [Related]  

  • 19. Electrophoretic fractionation of guniea pig lymphocytes: evidence for different subsets of T and B cells in spleen and lymph node.
    Anderson LC; Nordling S; Häyry P
    J Immunol; 1975 Apr; 114(4):1226-9. PubMed ID: 1090669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered lymphocyte functions in rats bearing syngeneic Moloney sarcoma tumors. II. Suppressor cells.
    Veit BC; Feldman JD
    J Immunol; 1976 Aug; 117(2):655-60. PubMed ID: 950466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.